Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. The Journal of experimental medicine, Feb, vol.16, issue.2062, pp.299-311, 2009. ,
A homozygous CARD9 mutation in a family with susceptibility to fungal infections, pp.1727-1762, 2009. ,
Human dectin-1 deficiency and mucocutaneous fungal infections. The New England journal of medicine, pp.1760-1767, 2009. ,
DOI : 10.1056/nejmoa0901053
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773015
Candida and Oral Candidosis: A Review, Critical Reviews in Oral Biology & Medicine, vol.5, issue.2, pp.125-57, 1994. ,
DOI : 10.1177/10454411940050020101
Antimicrobials as a contributory factor in oral candidosis--a brief overview. Oral diseases, pp.138-181, 2008. ,
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Annals of hematology, pp.565-574, 2003. ,
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections, Clinical Infectious Diseases, vol.24, issue.2, pp.235-282, 1997. ,
DOI : 10.1093/clinids/24.2.235
Guidelines for Treatment of Candidiasis, Clinical Infectious Diseases, vol.38, issue.2, pp.161-89, 2004. ,
DOI : 10.1086/380796
Clinical Perspective Oropharyngeal Candidiasis in Patients with HIV: Suggested Guidelines for Therapy, AIDS Research and Human Retroviruses, vol.15, issue.18, pp.1619-1642, 1999. ,
DOI : 10.1089/088922299309658
Prise en charge médicale des personnes infectées par le VIH Recommandation du groupe d'experts, Flammarion. Section, vol.15, p.296, 2008. ,
Recommandations pour la pratique clinique: Nice ? Saint-Paul-de- Vence 2009 « cancers du sein » et « soins de support ». Partie II ? Soins de Support ,
Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis, Cancer, vol.4, issue.1, pp.204-211, 2008. ,
DOI : 10.1002/cncr.23152
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? The Journal of antimicrobial chemotherapy, pp.384-410, 2006. ,
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009. ,
DOI : 10.1086/596757
Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer, pp.44-51, 2006. ,
Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. The Journal of antimicrobial chemotherapy, pp.973-84, 1993. ,
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS, Clinical Infectious Diseases, vol.27, issue.6, pp.1369-75, 1998. ,
DOI : 10.1086/515018
Recommandations de Saint-Paul-de-Vence Soins de support " Candidoses oropharyngées, Oncologie, vol.11, pp.682-686, 2009. ,